A Multicenter, Randomized, Controlled Study to Assess Mitral vAlve reconsTrucTion for advancEd Insufficiency of Functional or iscHemic ORigiN
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 210 participants.
Also called NCT02371512
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 210 participants
- Sponsor
- Universitätsklinikum Köln
- Registry
-
NCT02371512
-
- Other papers using this trial's data
- Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Unknown status
Technical summary
Registry record NCT02371512. Randomized; no masking; primary purpose treatment. Start 2015-02 (registry gives no type); primary completion 2019-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Multicenter, Randomized, Controlled Study to Assess Mitral vAlve reconsTrucTion for advancEd Insufficiency of Functional or iscHemic ORigiN
- Acronym
- MATTERHORN
- Condition
- Mitral Valve Insufficiency
- Intervention (Device)
- MitraClip system (Abbott Vascular, Menlo Park, USA)
- Intervention (Procedure)
- Mitral valve surgery
- Lead sponsor
- Universitätsklinikum Köln
- Collaborator
- The Clinical Trials Centre Cologne
Record details
- Record id
cardio:ct-nct02371512- Content hash
fcef5adc4c4830c0e7f4edf9809444c41f5001cf809c7529b743ba00da76773c